We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Ikano’s Midazolam for Seizures Gets Orphan Designation
Ikano’s Midazolam for Seizures Gets Orphan Designation
November 13, 2009
Ikano Therapeutics’ anti-epileptic drug midazolam has received an orphan drug designation from the FDA.